Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 28, 2025Gene TherapyOpen Access

Multi-targeting zinc finger nuclease vector unsilences paternal UBE3A in a mouse model of Angelman syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

HBHannah O. BazickLJLucas M. JamesBTBonnie Taylor-Blake

Discussion

Loading...

Member takes

Overview

Gene therapy finds zinc finger nuclease delivery restores paternal UBE3A expression in neurons, indicating potential for therapeutics.

Key Points

  • Restoration of paternal UBE3A expression occurs following zinc finger nuclease treatment in neuron cultures.
  • Significant findings include UBE3A levels resembling wild-type in some neurons of the AS-model mouse.
  • Gene therapy facilitated by adeno-associated virus demonstrates specificity by targeting only designated sites.
  • Potential therapeutic implications suggest addressing neurodevelopmental disorders like Angelman syndrome may be possible.

Cite This Study

Bazick et al. (2025) studied this question.

synapsesocial.com/papers/6928f113a65b730b9ea79fcchttps://doi.org/10.1038/s41434-025-00582-1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Multi-targeting zinc finger nuclease vector unsilences paternal UBE3A in a mouse model of Angelman syndrome2025 · 5 citations
  2. 2Nickase NmCas9 unsilences paternal Ube3a in a mouse model of Angelman syndrome without causing AAV vector integration2026
  3. 3AAV-dCas9 vector unsilences paternal Ube3a in neurons by impeding Ube3a-ATS transcription2025 · 6 citations
  4. 4Ube3a unsilencer for the potential treatment of Angelman syndrome2024 · 9 citations
  5. 5RNAi-Induced Expression of Paternal UBE3A2026 · 1 citations